Bright! FRONTEO Official Blog

Bright! FRONTEO Official Blog

[Webinar held on November 11] Introducing the information strategy support AI "Word ATLAS", a useful support tool for formulating pharmaceutical marketing and medical strategies.

Do you have such a problem?
・ It takes time to analyze the research contents and presentation contents of many academia and research institutes.
・ Limited information that can be used as a reference for formulating medical marketing strategies
・ Timely information analysis including competitive analysis is not possible (information analysis is performed by methods such as market research).
・ When performing information analysis or KOL analysis, it is limited to a specific region (domestic, overseas, etc.)

In this seminar, we will introduce "Word ATLAS", a system that analyzes and visualizes medical papers and author information contained in PubMed * using FRONTEO's original natural language analysis AI engine "Concept Encoder". "Word ATLAS" improves the efficiency of research and development in the fields of medicine and drug discovery as a support tool for selecting collaborators and collaborative facilities in basic research, clinical research, and clinical trials, and formulating medical marketing strategies including competitive analysis. We support the promotion of acceleration and sharing of knowledge.

 


【Webinar Summary】

◆ Theme: Introducing the information strategy support AI "Word ATLAS", a useful support tool for formulating pharmaceutical marketing and medical strategies.
◆ Date: November 2021, 11 (Monday) 29: 17-00: 17
◆ Recommended for people like this!
・ Those who work for a pharmaceutical company
・ Persons in charge of R & D, Business Development Department, Marketing Department, etc.
・ Those who want to improve work efficiency by utilizing AI
 
 

 
Speakers

Masato Takahashi (FRONTEO Inc. Executive Officer / General Manager of Life Science AI Business Headquarters)
 
After joining Astellas Pharma (formerly Fujisawa Pharmaceutical), after working in a sales position (MR), became a product manager at the sales headquarters.Experience new launches and expanded indications of various products from the primary area to the specialty area (organ / bone marrow transplantation, autoimmune diseases, rare diseases, respiratory diseases, allergic diseases, etc.).After that, as a new product planning, he was involved in the evaluation of product marketability and business feasibility, and from 2014, he experienced the formulation of business plans and the design and operation of a dedicated organization as the director of the transplant immunology area. Joined SymBio Pharmaceuticals Limited, a pharmaceutical bio-venture in 2016.He was involved in the launch of the blood cancer business as a marketing head, and later became the general manager of the company's sales and marketing division.In addition to building an in-house sales (pharmaceutical manufacturer / distributor) system specializing in the blood field and building a digital system, he is engaged in licensing business and alliance management.
Participated in FRONTEO in 2019, planning and directing business strategy for medical device development and launch using the world's first language analysis AI. Build a new business model for drug discovery and drug repositioning that utilizes AI technology. Appointed executive officer in 2021. Aiming to become the global leader as a life science company that integrates AI and medical care. 
 

Articles in the same category

Commonly viewed articles

ja 日本語
Machine Translation by Google. : close x